• Ramucirumab (brand name Cyramza) is a fully human monoclonal antibody (IgG1) developed for the treatment of solid tumors. This drug was developed by ImClone...
    14 KB (1,302 words) - 07:55, 1 July 2024
  • Thumbnail for Insulin
    Quizartinib Ripretinib Sunitinib Sorafenib Toceranib Antibodies: Olaratumab Ramucirumab Tovetumab RET (GFL) SCF (c-Kit) Agonists: Ancestim Stem cell factor Kinase...
    121 KB (13,799 words) - 06:42, 1 July 2024
  • Thumbnail for Merestinib
    PMC 5862616. PMID 29568395. Clinical trial number NCT02711553 for "A Study of Ramucirumab (LY3009806) or Merestinib (LY2801653) in Advanced or Metastatic Biliary...
    4 KB (157 words) - 14:30, 19 November 2023
  • Thumbnail for Lung cancer
    the above are treated with second-line chemotherapeutics docetaxel and ramucirumab. Integrating palliative care (medical care focused on improving symptoms...
    90 KB (9,784 words) - 14:55, 21 June 2024
  • Quizartinib Ripretinib Sunitinib Sorafenib Toceranib Antibodies: Olaratumab Ramucirumab Tovetumab RET (GFL) SCF (c-Kit) Agonists: Ancestim Stem cell factor Kinase...
    13 KB (1,177 words) - 16:45, 16 July 2024
  • Thumbnail for Monoclonal antibody therapy
    antibodies can be targeted against malignant cells by several mechanisms. Ramucirumab is a recombinant human monoclonal antibody and is used in the treatment...
    57 KB (4,072 words) - 07:13, 1 July 2024
  • (INN) ramnodigin (INN) ramoplanin (INN) ramorelix (INN) ramosetron (INN) ramucirumab (USAN) ranagengliotucel-T (USAN) ranelic acid (INN) ranibizumab (INN)...
    5 KB (284 words) - 04:36, 2 July 2024
  • Thumbnail for Dehydroepiandrosterone
    Quizartinib Ripretinib Sunitinib Sorafenib Toceranib Antibodies: Olaratumab Ramucirumab Tovetumab RET (GFL) SCF (c-Kit) Agonists: Ancestim Stem cell factor Kinase...
    42 KB (3,935 words) - 04:01, 30 April 2024
  • Thumbnail for Testosterone
    Quizartinib Ripretinib Sunitinib Sorafenib Toceranib Antibodies: Olaratumab Ramucirumab Tovetumab RET (GFL) SCF (c-Kit) Agonists: Ancestim Stem cell factor Kinase...
    150 KB (15,741 words) - 10:54, 25 July 2024
  • Thumbnail for Dexamethasone
    Quizartinib Ripretinib Sunitinib Sorafenib Toceranib Antibodies: Olaratumab Ramucirumab Tovetumab RET (GFL) SCF (c-Kit) Agonists: Ancestim Stem cell factor Kinase...
    68 KB (5,996 words) - 02:41, 17 July 2024